These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
582 related items for PubMed ID: 28131417
1. miR-18a-5p Inhibits Sub-pleural Pulmonary Fibrosis by Targeting TGF-β Receptor II. Zhang Q, Ye H, Xiang F, Song LJ, Zhou LL, Cai PC, Zhang JC, Yu F, Shi HZ, Su Y, Xin JB, Ma WL. Mol Ther; 2017 Mar 01; 25(3):728-738. PubMed ID: 28131417 [Abstract] [Full Text] [Related]
2. Crosstalk between pleural mesothelial cell and lung fibroblast contributes to pulmonary fibrosis. Liu F, Yu F, Lu YZ, Cheng PP, Liang LM, Wang M, Chen SJ, Huang Y, Song LJ, He XL, Xiong L, Xin JB, Ma WL, Ye H. Biochim Biophys Acta Mol Cell Res; 2020 Nov 01; 1867(11):118806. PubMed ID: 32739525 [Abstract] [Full Text] [Related]
3. miR-9-5p suppresses pro-fibrogenic transformation of fibroblasts and prevents organ fibrosis by targeting NOX4 and TGFBR2. Fierro-Fernández M, Busnadiego Ó, Sandoval P, Espinosa-Díez C, Blanco-Ruiz E, Rodríguez M, Pian H, Ramos R, López-Cabrera M, García-Bermejo ML, Lamas S. EMBO Rep; 2015 Oct 01; 16(10):1358-77. PubMed ID: 26315535 [Abstract] [Full Text] [Related]
7. Inhibition of miR-182-5p attenuates pulmonary fibrosis via TGF-β/Smad pathway. Chen Y, Zhang Q, Zhou Y, Yang Z, Tan M. Hum Exp Toxicol; 2020 May 01; 39(5):683-695. PubMed ID: 31884830 [Abstract] [Full Text] [Related]
9. USP7 Promotes TGF-β1 Signaling by De-Ubiquitinating Smad2/Smad3 in Pulmonary Fibrosis. Tang F, Gong H, Ke T, Yang W, Yang Y, Liu Z. Discov Med; 2024 Aug 01; 36(187):1616-1626. PubMed ID: 39190377 [Abstract] [Full Text] [Related]
12. Tetraspanin 1 as a mediator of fibrosis inhibits EMT process and Smad2/3 and beta-catenin pathway in human pulmonary fibrosis. Liu G, Wang Y, Yang L, Zou B, Gao S, Song Z, Lin Z. J Cell Mol Med; 2019 May 01; 23(5):3583-3596. PubMed ID: 30869194 [Abstract] [Full Text] [Related]
14. Downregulation of microRNA-9 reduces inflammatory response and fibroblast proliferation in mice with idiopathic pulmonary fibrosis through the ANO1-mediated TGF-β-Smad3 pathway. Dai WJ, Qiu J, Sun J, Ma CL, Huang N, Jiang Y, Zeng J, Ren BC, Li WC, Li YH. J Cell Physiol; 2019 Mar 01; 234(3):2552-2565. PubMed ID: 30144053 [Abstract] [Full Text] [Related]
16. VEGF/Src signaling mediated pleural barrier damage and increased permeability contributes to subpleural pulmonary fibrosis. Lu YZ, Liang LM, Cheng PP, Xiong L, Wang M, Song LJ, Yu F, He XL, Xiong L, Wang XR, Xin JB, Ye H, Ma WL. Am J Physiol Lung Cell Mol Physiol; 2021 Jun 01; 320(6):L990-L1004. PubMed ID: 33787325 [Abstract] [Full Text] [Related]
19. Integrated analyses identify the involvement of microRNA-26a in epithelial-mesenchymal transition during idiopathic pulmonary fibrosis. Liang H, Gu Y, Li T, Zhang Y, Huangfu L, Hu M, Zhao D, Chen Y, Liu S, Dong Y, Li X, Lu Y, Yang B, Shan H. Cell Death Dis; 2014 May 22; 5(5):e1238. PubMed ID: 24853416 [Abstract] [Full Text] [Related]
20. The anti-fibrotic effects of microRNA-153 by targeting TGFBR-2 in pulmonary fibrosis. Liang C, Li X, Zhang L, Cui D, Quan X, Yang W. Exp Mol Pathol; 2015 Oct 22; 99(2):279-85. PubMed ID: 26216407 [Abstract] [Full Text] [Related] Page: [Next] [New Search]